Emerging Markets Earnings: Key Geographies Underpin Pfizer’s Bold Plans
This article was originally published in PharmAsia News
Executive Summary
Pfizer received support from emerging market sales in the third quarter that for now allows Ian Read to continue to search for bold stroke acquisitions or other plays.